News

The European Commission has published a new version of the Questions & Answers (Q&A) document on “Safety Features for Medicinal Products for Human Use (V.21)”.

Ko izgaismo un kādas mācības sniedz Ozempic gadījums? Visa zāļu verifikācijas sistēmas kopiena Eiropā ļoti uzmanīgi seko “Ozempic gadījumam”, un Latvija nav izņēmums. Lai arī šobrīd mūsu valstī nav konstatēti šo zāļu viltojumi, mums nav nekādu garantiju, ka tas nevar notikt rīt vai pēc mēneša.

The European Medicines Verification Organisation (EMVO) has launched the EMVS Community Newsletter - edition April 2024. This month, newsletter focusing on Data Quality, featuring insights from EMVO, the Dutch NMVO, Accord Healthcare, and end-user perspectives from the healthcare sector.

LZVO releases newsletter No. 9, where you can find the most important information about events in verification system and our neighbors in Lithuania sharing their experience story.

While setting up the Lithuanian Medicines Verification Organization (NVVO) came with its challenges in the beginning, ever since its founding back in 2017 we have not swayed from our goal: to ensure the safety of medicines for patients.

LZVO (Latvijas Zāļu verifikācijas organizācija) releases newsletter No. 8, where you can find the most important information about events in the world of pharmaceutical verification in 2024 as well on the previous five years. Also our neighbors in Estonia sharing their experience story.